The effect of sleep-disordered breathing (SDB) on adverse consequences associated with opioid use: A population study

T. Kendzerska (Ottawa, Canada), T. Gomes (Toronto, Canada), A. Malhotra (San Diego, United States of America), A. Gershon (Toronto, Canada), M. Povitz (Calgary, Canada), D. Mcisaac (Ottawa, Canada), S. Aaron (Ottawa, Canada), F. Chung (Toronto, Canada), G. Bryson (Ottawa, Canada), R. Talarico (Ottawa, Canada), T. Ahmed (Ottawa, Canada), M. Godbout (Ottawa, Canada), P. Tanuseputro (Ottawa, Canada)

Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases
Session: Determinants of chronic respiratory diseases
Session type: E-poster session
Number: 424
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kendzerska (Ottawa, Canada), T. Gomes (Toronto, Canada), A. Malhotra (San Diego, United States of America), A. Gershon (Toronto, Canada), M. Povitz (Calgary, Canada), D. Mcisaac (Ottawa, Canada), S. Aaron (Ottawa, Canada), F. Chung (Toronto, Canada), G. Bryson (Ottawa, Canada), R. Talarico (Ottawa, Canada), T. Ahmed (Ottawa, Canada), M. Godbout (Ottawa, Canada), P. Tanuseputro (Ottawa, Canada). The effect of sleep-disordered breathing (SDB) on adverse consequences associated with opioid use: A population study. 424

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of CPAP on neurocognitive function in sleep-disordered breathing: why are the signals so weak?
Source: International Congress 2015 – Does sleep apnoea impact cognitive function?
Year: 2015

Changes of polygraphic findings associated to sleep-disordered breathing (SDB) after sexual development in an adolescent population
Source: Eur Respir J 2002; 20: Suppl. 38, 575s
Year: 2002

Functional outcomes of surgical treatment children's sleep-disordered breathing (SDB)
Source: Eur Respir J 2001; 18: Suppl. 33, 420s
Year: 2001

Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012



Severe sleep apnea during REM sleep is associated with decreased levels of anti-inflammatory proteins - A proteomic approach to study the impact of sleep-disordered breathing
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019

Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS?
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007

Increased mortality rate associated with prescribed opioid medications: is there a link with sleep disordered breathing?
Source: Eur Respir J 2005; 26: Suppl. 49, 596s
Year: 2005

Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Wheezing and symptoms related to sleep-disordered breathing: a population-based study
Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases
Year: 2008


Impact of daytime sleepiness on work performance in sleep-disordered breathing (SDB)
Source: Eur Respir J 2004; 24: Suppl. 48, 112s
Year: 2004

Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB)
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011

Interaction between obesity, pulmonary disease and sleep-disordered breathing (SDB)
Source: International Congress 2016 – Complex breathing disorders during sleep
Year: 2016


Sleep-disordered breathing (SDB) and obstructive sleep apnea (OSA) in elderly population with high and low BMI
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011


CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence.
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017


Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment
Source: Eur Respir Monogr 2020; 88: 118-142
Year: 2020


Influence of smoking on symptoms, comorbidities and severity in a population with obstructive sleep apnea (OSA) versus control
Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Year: 2011


Treatment of sleep-disordered breathing with positional therapy: long-term results
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018




Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
Source: Eur Respir J 2009; 33: 1062-1067
Year: 2009



The impact of sleep-disordered breathing on the human brain: from children via mice, to adults
Source: International Congress 2015 – Does sleep apnoea impact cognitive function?
Year: 2015



Residual sleep apnea on CPAP: prevalence, predictors and patterns
Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea
Year: 2008